Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.2105 USD
−114.31 M USD
60.51 M USD
226.49 M
About Adaptimmune Therapeutics plc
Sector
Industry
CEO
Adrian Rawcliffe
Website
Headquarters
Abingdon
Founded
2014
FIGI
BBG008G65WC2
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.